A detailed history of Independent Advisor Alliance transactions in Viatris Inc stock. As of the latest transaction made, Independent Advisor Alliance holds 54,244 shares of VTRS stock, worth $705,172. This represents 0.02% of its overall portfolio holdings.

Number of Shares
54,244
Previous 74,624 27.31%
Holding current value
$705,172
Previous $793,000 20.68%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$10.32 - $12.13 $210,321 - $247,209
-20,380 Reduced 27.31%
54,244 $629,000
Q2 2024

Aug 12, 2024

BUY
$10.05 - $12.02 $368,975 - $441,302
36,714 Added 96.85%
74,624 $793,000
Q1 2024

May 08, 2024

BUY
$11.27 - $13.53 $231,970 - $278,487
20,583 Added 118.79%
37,910 $452,000
Q4 2023

Feb 08, 2024

BUY
$8.77 - $10.85 $12,646 - $15,645
1,442 Added 9.08%
17,327 $187,000
Q3 2023

Oct 24, 2023

BUY
$9.59 - $11.35 $52,188 - $61,766
5,442 Added 52.11%
15,885 $156,000
Q2 2023

Jul 28, 2023

BUY
$9.02 - $10.29 $94,195 - $107,458
10,443 New
10,443 $104,000
Q3 2022

Nov 04, 2022

SELL
$8.48 - $11.13 $10,294 - $13,511
-1,214 Reduced 10.74%
10,085 $86,000
Q2 2022

Aug 04, 2022

SELL
$9.95 - $12.27 $16,586 - $20,454
-1,667 Reduced 12.86%
11,299 $118,000
Q1 2022

May 06, 2022

BUY
$9.81 - $15.4 $16,794 - $26,364
1,712 Added 15.21%
12,966 $141,000
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $12,295 - $14,929
-1,017 Reduced 8.29%
11,254 $152,000
Q3 2021

Nov 01, 2021

SELL
$13.25 - $15.13 $16,854 - $19,245
-1,272 Reduced 9.39%
12,271 $166,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $236,469 - $294,446
-18,232 Reduced 57.38%
13,543 $194,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $139,854 - $190,795
-10,291 Reduced 24.46%
31,775 $444,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $601,543 - $788,316
42,066 New
42,066 $788,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.